In December 2025, the U.S. Food and Drug Administration (FDA) approved the addition of meningioma brain tumor risks to the warning labels for Depo-Provera®, a…
Personal Injury Lawyers Serving the Entire U.S.
In December 2025, the U.S. Food and Drug Administration (FDA) approved the addition of meningioma brain tumor risks to the warning labels for Depo-Provera®, a…
Meningiomas are the most common type of brain tumor, accounting for about 30% of all diagnosed brain tumors in the United States, according to Johns…
For years, Depo-Provera® has been marketed as a convenient, long-acting birth control option. However, behind its promise of ease lies a growing concern: Depo shots…
![]()
Hello, we're sorry to barge in, but we are available to answer your questions.
Would you like to speak to a live person?